CalciMedica Inc. Common Stock (CALC)
Stock · NASDAQ · Health Care
$0.464as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$0.609925
Industry
Biotechnology: Pharmaceutical Preparations
About CALC
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidne…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 16
- Website
- calcimedica.com/
Fundamentals
- 1-day range
- $0.44$0.4753
- Market cap
- $23.14M
- P/E (trailing)
- —
- P/E (forward)
- -0.28
- EPS (trailing)
- $-1.29
- Dividend yield
- —
- Beta
- 0.71
- Avg. volume
- 1.37M
52-week range
$0.4606$7.2
Forecasts
3 analyst ratings
Buy 78%
Hold 22%
Sell 0%
1-year price forecast
High
$15
+3132.8%
Median
$9
+1839.7%
Low
$6
+1193.1%
CalciMedica Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CALCCalciMedica Inc. Common Stock$0.4644▼ 1.19%Market cap $23.14MP/E —$0.4606$7.2
- LGVNLongeveron Inc. Class A Common Stock$6.72▼ 1.47%Market cap $23.13MP/E —$4.75$12.3
- BRNSBarinthus Biotherapeutics plc American Depositary Shares$0.7464▲ 2.11%Market cap $24.51MP/E —$0.512$1.83
- CLRBCellectar Biosciences Inc. Common Stock$2.54▲ 0.00%Market cap $21.26MP/E —$2.2$6.52
- NEUPNeuphoria Therapeutics Inc. Common Stock$3.82▲ 1.33%Market cap $21.24MP/E —$3.19$21.4
- TVRDTvardi Therapeutics Inc. Common Stock$1.8▲ 0.00%Market cap $25.13MP/E —$1.5$43.65
- ACTUActuate Therapeutics Inc. Common stock$1.67▼ 1.18%Market cap $25.36MP/E —$0.9$9.22
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CALC CalciMedica Inc. Common Stock | $23.14M | — | $0.4644 | ▼ 1.19% | $0.4606$7.2 |
| LGVN Longeveron Inc. Class A Common Stock | $23.13M | — | $6.72 | ▼ 1.47% | $4.75$12.3 |
| BRNS Barinthus Biotherapeutics plc American Depositary Shares | $24.51M | — | $0.7464 | ▲ 2.11% | $0.512$1.83 |
| CLRB Cellectar Biosciences Inc. Common Stock | $21.26M | — | $2.54 | ▲ 0.00% | $2.2$6.52 |
| NEUP Neuphoria Therapeutics Inc. Common Stock | $21.24M | — | $3.82 | ▲ 1.33% | $3.19$21.4 |
| TVRD Tvardi Therapeutics Inc. Common Stock | $25.13M | — | $1.8 | ▲ 0.00% | $1.5$43.65 |
| ACTU Actuate Therapeutics Inc. Common stock | $25.36M | — | $1.67 | ▼ 1.18% | $0.9$9.22 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- CalciMedica Announces 1-For-5 Reverse Stock Split, Effective August 28benzinga · 8/27/2026
- CalciMedica Announces 1-For-5 Reverse Stock Split, Effective August 28Benzinga · 8/27/2026
- Guggenheim Initiates Coverage On CalciMedica with Buy Rating, Announces Price Target of $9Benzinga · 8/20/2026
- CalciMedica Q2 EPS $(0.45) Misses $(0.28) EstimateBenzinga · 8/11/2026
- Which stocks are experiencing notable movement on Monday?ChartMill · 8/3/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 8/3/2026
- Top stock movements in today's session.ChartMill · 8/3/2026
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga · 8/3/2026
Insider Activity
Insider Actions →Acquired
3.55M
Disposed
0
- ALAFI CAPITAL CO LLC · August 19, 2026 · Grant3.53M
- Zaytsev Evgeny · July 2, 2026 · Grant20.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 1.07M
- Total value held
- $501.7K
- Institutional holders
- 27
Top holders this quarter
- Unknown178.5K
- Unknown169.1K
- Unknown128.1K
- Unknown126.5K
- Unknown123.4K
- Unknown60.0K
- Unknown53.7K
- Unknown39.7K
- Unknown30.7K
- Unknown23.8K
See the full, filterable feed with live charts on the MarketWall dashboard.